000 01621 a2200469 4500
005 20250517234908.0
264 0 _c20181213
008 201812s 0 0 eng d
022 _a1471-2490
024 7 _a10.1186/s12894-018-0390-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNazir, Jameel
245 0 0 _aA retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain.
_h[electronic resource]
260 _bBMC urology
_cSep 2018
300 _a76 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Observational Study
650 0 4 _aAcetanilides
_xtherapeutic use
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLinear Models
650 0 4 _aLongitudinal Studies
650 0 4 _aMale
650 0 4 _aMedication Adherence
650 0 4 _aMiddle Aged
650 0 4 _aMuscarinic Antagonists
_xtherapeutic use
650 0 4 _aProportional Hazards Models
650 0 4 _aRetrospective Studies
650 0 4 _aSpain
650 0 4 _aThiazoles
_xtherapeutic use
650 0 4 _aUrinary Bladder, Overactive
_xdrug therapy
650 0 4 _aUrological Agents
_xtherapeutic use
700 1 _aHakimi, Zalmai
700 1 _aGuelfucci, Florent
700 1 _aKhemiri, Amine
700 1 _aFatoye, Francis
700 1 _aBlázquez, Ana María Mora
700 1 _aGonzález, Marta Hernández
773 0 _tBMC urology
_gvol. 18
_gno. 1
_gp. 76
856 4 0 _uhttps://doi.org/10.1186/s12894-018-0390-z
_zAvailable from publisher's website
999 _c28801704
_d28801704